436 related articles for article (PubMed ID: 24599767)
21. Clinical features and prognostic factors in severe cutaneous drug reactions.
Yang MS; Kang MG; Jung JW; Song WJ; Kang HR; Cho SH; Min KU
Int Arch Allergy Immunol; 2013; 162(4):346-54. PubMed ID: 24193402
[TBL] [Abstract][Full Text] [Related]
22. Medication Associations With Severe Cutaneous Adverse Reactions: A Case/Non-Case Analysis Using the FDA Adverse Event Reporting System.
Godfrey H; Jedlowski P; Thiede R
J Cutan Med Surg; 2024; 28(1):51-58. PubMed ID: 38189282
[TBL] [Abstract][Full Text] [Related]
23. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?
Bouvresse S; Valeyrie-Allanore L; Ortonne N; Konstantinou MP; Kardaun SH; Bagot M; Wolkenstein P; Roujeau JC
Orphanet J Rare Dis; 2012 Sep; 7():72. PubMed ID: 23009177
[TBL] [Abstract][Full Text] [Related]
24. The life-threatening eruptions of immune checkpoint inhibitor therapy.
Coleman EL; Olamiju B; Leventhal JS
Clin Dermatol; 2020; 38(1):94-104. PubMed ID: 32197753
[TBL] [Abstract][Full Text] [Related]
25. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
26. Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia.
AlJasser MI
Dermatol Res Pract; 2023; 2023():8928198. PubMed ID: 37206671
[TBL] [Abstract][Full Text] [Related]
27. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
Darlenski R; Kazandjieva J; Tsankov N
Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
[TBL] [Abstract][Full Text] [Related]
28. Association between
Wattanachai P; Amornpinyo W; Konyoung P; Purimart D; Khunarkornsiri U; Pattanacheewapull O; Tassaneeyakul W; Nakkam N
Front Pharmacol; 2023; 14():1248386. PubMed ID: 37795024
[No Abstract] [Full Text] [Related]
29. Outpatient management and follow-up recommendations for adverse drug reactions: guidelines for posthospitalization care.
Khanna R; Vaudreuil A; Lake E
Cutis; 2019 May; 103(5):254-256;258. PubMed ID: 31233575
[TBL] [Abstract][Full Text] [Related]
30. Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.
Mustafa SS; Ostrov D; Yerly D
Curr Allergy Asthma Rep; 2018 Mar; 18(4):26. PubMed ID: 29574562
[TBL] [Abstract][Full Text] [Related]
31. Severe adverse drug reactions.
Teo YX; Walsh SA
Clin Med (Lond); 2016 Feb; 16(1):79-83. PubMed ID: 26833523
[TBL] [Abstract][Full Text] [Related]
32. Severe cutaneous adverse reactions to antiepileptic drugs in Asians.
Yang CY; Dao RL; Lee TJ; Lu CW; Yang CH; Hung SI; Chung WH
Neurology; 2011 Dec; 77(23):2025-33. PubMed ID: 22116946
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea.
Kang MG; Sohn KH; Kang DY; Park HK; Yang MS; Lee JY; Kang HR
Yonsei Med J; 2019 Feb; 60(2):208-215. PubMed ID: 30666843
[TBL] [Abstract][Full Text] [Related]
34. Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Antibiotic Use: A Case-Crossover Study.
Fukasawa T; Urushihara H; Takahashi H; Okura T; Kawakami K
J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3463-3472. PubMed ID: 37459954
[TBL] [Abstract][Full Text] [Related]
35. Severe acute generalized exanthematous pustulosis with blistering mimicking toxic epidermal necrolysis, associated with a primary mumps infection.
Azib S; Florin V; Fourrier F; Delaporte E; Staumont-Sallé D
Clin Exp Dermatol; 2014 Aug; 39(6):723-5. PubMed ID: 24986490
[TBL] [Abstract][Full Text] [Related]
36. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
38. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.
Huang YS; Wu CY; Chang TT; Peng CY; Lo GH; Hsu CW; Hu CT; Huang YH
Liver Int; 2021 Nov; 41(11):2671-2680. PubMed ID: 34153177
[TBL] [Abstract][Full Text] [Related]
40. Adverse drug reactions and organ damage: The skin.
Marzano AV; Borghi A; Cugno M
Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
